Couple-years of protection (CYP) is one of several commonly used indicators to assess international family planning efforts. It has been the subject of much debate, relating in part to the specific conversion factors used to translate the quantity of the respective contraceptive methods distributed to a single measure of protection. This article outlines a comprehensive effort to revisit those conversion factors based on the best available empirical evidence. In most instances, the analysis supports previously established standard conversion factors. However, there are two notable departures. Fewer condoms and spermicides are recommended for each CYP (120 vs. 150), primarily because coital frequency among condom users is lower than previously assumed. Furthermore, for sterilization, the authors recommend the use of country or region-specific conversion factors. Every program evaluation indicator has strengths and weaknesses, and the best program evaluation efforts use a variety of indicators. If CYP is used to evaluate programs, however, the authors believe that the conversion factors presented reflect the best available evidence.
Get full access to this article
View all access options for this article.
References
1.
Akbar, J.
, J. Chakraborty, N. Jahan, J. Phillips, and A. Satterthwaite. 1982. Dynamics of Depot Medroxy Projesterone Acetate (DMPA): Use-effectiveness in the Matlab family planning health services project. Unpublished manuscript.
2.
Apelo, R. A.
, R. M. Ramos, E. Bernardo, and C. B. Champion. 1989. A 3-year evaluation of the Tcu380Ag and the CU-7. International Journal of Gynœcological Obstetrics28: 269-273.
3.
AVSC International
. 1992. PTS report: Clients'female mean age and parity by country and year, report 01. New York: Author.
4.
Banerjee, S.
, R. Baweja, R. Bhatt, A. Chatterjee, S. Choudhury, B. Coyaji, A. Engineer, M. Gogoi, V. Hingorani, K. Kasturilal, M. Kochar, U. Kirshna, P. Misra, F. Phillips, R. Rajan, P. Sengupta, and K. Zaveri. 1984. Comparative evaluation of contraceptive efficiency of Norethisterone Oenanthate (200 mg) injectable contraceptive given every two or three months. Contraception30 (6): 561-574.
5.
Batár, I.1988. Clinical experiences with the spring coil intrauterine device: A ten-year follow-up study. International Journal of Gynœcological Obstetrics27 (1): 123-131.
6.
Becker, S.
, and S. Begum. 1994. Reliability study of reporting of days since last sexual intercourse in Matlab, Bangladesh. Journal of Biosocial Science26 (3): 291-299.
7.
Bertrand, J. T.
, R. Magnani, and J. Knowles. 1994. Handbook of indicators for family planning program evaluation. Chapel Hill, NC: The EVALUATION Project, Carolina Population Center.
8.
Blanc, A. K.
, and N. Rutenberg. 1991. Coitus and contraception: The utility of data on sexual intercourse for family planning programs. Studies in Family Planning22 (3): 162-176.
9.
Catania, J. A.
, D. R. Gibson, D. D. Chitwood, and T. J. Coates. 1990. Methodological problems in AIDS behavioral research: Influences on measurement error and participation bias in studies of sexual behavior. Psychological Bulletin108: 339-362.
10.
Centers for Disease Control
. 1993. Family planning logistics guidelines. Atlanta, GA: Author.
11.
Champion, C. B.
, B. Behlilovic, J. M. Arosemana, L. Randic, L. P. Cole, and L. R. Wilsens. 1988. A three-year evaluation of Tcu380ag and multiload CU 375 intrauterine devices. Contraception38 (6): 631-639.
12.
Chaudhury, N.
, N. Gupta, M. Hazra, V. Hingorani, M. Kochhar, B. Kodkany, A. Logambal, U. Nanda, P. Raja Ram, G. Rai Choudhury, N. Sathiavathy, P. Sengupta, R. Sivaraman, U. Sutaria, and K. Zaveri. 1988. Phase III clinical trials with Norplant-2 (covered rods): Report of a 24-month study. Contraception38 (6): 659-673.
13.
Chowdhury, T.1985. A clinical study on injectable contraceptive Noristerat. Bangladesh Medical Journal14 (2,3): 28-35.
14.
Croxatto, H.
, S. Diaz, and I. Sivin. 1991. Contraceptive implants. Annals of New York Academy of Science626: 22-29.
15.
Cuervo, L. I.1991. Measuring natural family planning in terms of couple-years of protection. American Journal of Obstetrics and Gynecology16 (December): 2063-2065.
16.
Curtis, S. L.1994. The impact of postpartum redundant use of contraception on contraceptive failure rates. Paper presented at the Population Association of America (PAA) Conference, 5-7 May.
17.
Diaz, J.
, A. P. Neto, M. Diaz, N. M. Marchi, and L. Bahamondes. 1992. Long-term evaluation of the clinical performance of the Tcu200B and the TCu380A in Campinas, Brazil. Advances in Contraception8: 67-72.
18.
Diaz, S.
, M. Pavez, P. Miranda, E. Johansson, and H. Croxatto. 1987. Long-term follow-up of women treated with NORPLANT® implants. Contraception35 (6): 551-567.
19.
Diaz, S.
, M. Pavez, P. Miranda, I. Sivin, and H. Croxatto. 1984. Performance of Norplant subdermal implants in clinical studies in Chile. In Long-acting contraceptive delivery systems, edited by G. I. Zatuchni, A. Goldsmith, J. D. Shelton, and J. J. Sciarra, 482-487. Philadelphia: Harper & Row.
20.
Family Health International. 1997. Conversation with author.
21.
Folmar, S.
, S. M. Nurul Alam, and A.H.M. Raihan Sharif. 1992. Condom use in Bangladesh:Final report. 24 September. Dhaka, Bangladesh: U.S. Agency for International Development.
22.
Fort, A. L.1996. More evils of CYP. Studies in Family Planning27 (4): 228-231.
23.
Gorosh, M.
, and D. Wolfers. 1979. Standard couple-years of protection. In Manual IX: The methodology of measuring the impact of family planning programmes on fertility. New York: United Nations, Department of International Economic and Social Affairs.
24.
Gray, R. H.
, R. T. Kambic, C. A. Lanctot, M. C. Martin, R. Wesley, and R. Cremins. 1991. Evaluation of natural family planning programs in Liberia and Zambia. Baltimore: Johns Hopkins University, School of Hygiene and Public Health.
25.
Grubb, G.
, J. Welch, L. Cole, A. Goldsmith, and R. Viera. 1989. A comparative evaluation of the safety and contraceptive effectiveness of 65 mg and 100 mg of 90-day Norethindrone (NET) injectable microspheres: A multicenter study. Fertility and Sterility51 (5): 803-810.
26.
Hefnawi, F.
, M. Toppozada, M. Rizk, M. Shaaban, A. El Said, and A. Mustafa. 1983. Norplant clinical studies—Egypt. In Long-acting contraceptive delivery systems, edited by A. Goldsmith and M. Toppozada, 471-481. Philadelphia: Harper & Row.
27.
Hornsby, P. P.
, and A. Wilcox. 1989. Validity of questionnaire information on frequency of coitus. American Journal of Epidemiology130 (1): 94-99.
28.
Huber, D., M. Rahman, and J. Chakraborty. 1977. Injectable contraceptives in six villages of Matlab Thkana, Bangladesh: Initial experience. Unpublished manuscript.
29.
Janjua, S.1983. Comparative trials of Depo-Provera versus Norigest. In Proceedings: Eleventh seminar on research in population planning, 116-129. Pakistan: National Research Institute of Fertility Control.
30.
Johnson, T.1991. Memorandum to program performance indicators committee members on the subject of revised CYP factors. Unpublished manuscript.
31.
Kambic, R. T.
, R. H. Gray, R. St. Mart, C. A. Lanctot, and M. C. Martin. 1990. Client autonomy among natural family planning users in Mauritius. Baltimore: Johns Hopkins University, School of Hygiene and Public Health.
32.
Kesseru, E.1976. Long-acting injectable contraceptives. In Biological and clinical aspects of reproduction, edited by F. Ebling and I. Henderson, 365-374. International Congress Series No. 394. Amsterdam: Excepta Medica.
33.
Kirmeyer, S.
, and C. M. Suchindran. 1995. Model life tables for contraceptive use and couple-years of protection: A summary of findings. Chapel Hill: Research Triangle Institute and University of North Carolina.
34.
Koetsawang, S.
, S. Srisuphandit, S. Srivanaboon, P. Bhiraleus, D. Rachawat, O. Kiriwat, and A. Koetsawang. 1974. Intramuscular depomedroxyprogesterone acetate for contraception. Journal of the Medical Association of Thailand57 (8): 396-406.
35.
Labbok, M. H.1992. The lactational amenorrhea method: A new hormonal family planning method. Paper presented at the 40th Anniversary Meeting of the International Planned Parenthood Federation, October.
36.
Labbok, M. H.
, A. Perez, V. Valdes, F. Sevilla, K. Wade, V. H. Laukaran, K. A. Cooney, S. Coly, C. Sanders, and J. T. Queenan. 1994. The lactational amenorrhea method (LAM): A postpartum introductory family planning method with policy and program implications. Advances in Contraception10: 93-109.
37.
Laing, J. D.
, and D. Walker. 1987. A reassessment of the Bangladesh social marketing project's objectives and information needs. September. Washington, DC: POPTECH.
38.
Laukaran, V. H.
, S. O. Rutstein, M. H. Labbok, and E. Ballard. 1994. Contraceptive use during lactational amenorrhea: Estimates of double coverage among postpartum women using DHS I and II data. Paper presented at the Population Association of America (PAA) Conference, 5-7 May.
39.
Laukaran, V. H.
, and B. Winikoff. 1985. Contraceptive use, amenorrhea, and breastfeeding in postpartum women. Studies in Family Planning16: 293-300.
40.
Lopez, G.
, A. Rodriguez, and J. Rengifo. 1984. Prospective experience with a levonorgestrel implant—Norplant. Contraceptive Delivery Systems5: 293-302.
41.
Lopez, G.
, A. Rodriguez, J. Rengifo, and I. Sivin. 1986. Two-year prospective study in Colombia of Norplant implants. Obstetrics and Gynecology68 (2): 204-208.
42.
McDaniel, E.
, R. Gray, and T. Pardsthaisong. 1984. Method failure pregnancy rates with Depo-Provera and a local substitute. Lancet1 (8389): 1293-1293.
43.
Meade, C.
, L. Casarin, M. Diaz, A. Aquado, L. Zacarias, S. Holck, P. Diethelm, and J. Annus. 1984. A clinical study of norethisterone enanthate in rural Mexico. Studies in Family Planning15 (3): 143-148.
44.
Miller, K.
, M. Gorosh, M. Ojermark, P. Wondergen, and V. Hight-Laukeran. 1996. Family Planning Monitoring and Evaluation System (FPPMES). Arlington, VA: John Snow.
45.
Moreno, L.
, and N. Goldman. 1991. Contraceptive failure rates in developing countries: Evidence from Demographic and Health Surveys. Presented at the Annual Meeting of the Population Association of America, Washington, DC, March.
46.
Murphy, E. 1997. Telephone conversation with Bertrand, January.
47.
Ojo, O.1979. International forum: Acceptability and efficacy of DMPA. International Journal of Gynaecology and Obstetrics16 (5): 439-441.
48.
Pakshong, D., S. Yung, and S. Hu. 1969. Report of a study using long acting injectable contraceptives done by the family planning and population board on 750 women in Singapore. FPPB Paper No. 7. Singapore: Singapore Family Planning and Population Broad.
49.
Philliber, S. W.
, and W. W. Philliber. 1985. Social and psychological perspectives on voluntary sterilization: A review. Studies in Family Planning16 (1): 1-29.
50.
Pickering, H.1987. Asking questions on sexual behavior... testing methods from the social sciences. Health Policy and Planning3: 237-244.
51.
Ramos, R.
, L. Ricalde, A. Baldera, and L. Reynoso Ron. 1991. Implantes subdérmicos liberadores de levonorgestrel [Levonorgestral subdermal implants]. Ginecologia Y. Obstetricia de México59: 138-140.
52.
Randic, L. H. Haller
, M. Perovic, and G. Farr. 1991. The effect of adding copper onto Lippes Loop IUDs: Results from a ten-year study in Yugoslavia. Contraception43: 229-239.
53.
Rob, A. K.
, G. P. Cernada, K. A. Siddiqui, J. Naeem. 1993. Pakistan IUD follow-up survey 1992-93. Islamabad, Pakistan: Population Council.
54.
Ross, J.
, and C. B. Lloyd. 1992. Methods for measuring the fertility impact of family planning programmes: The experience of the last decade. In Family planning programmes and fertility, edited by J. F. Phillipes and J. A. Ross, 28-55. Oxford, UK: Clarendon.
55.
Rutenberg, N.1993. The fertility impact of inconsistent use of contraception. Washington, DC: The Futures Group International.
56.
Rutenberg, N.
, A. K. Blanc, and S. Kapiga. 1994. Sexual behaviour, social change and family planning among men and women in Tanzania. Health Transition Review4 (suppl.): 173-196.
57.
Sastrawinata, S.
, G. Farr, S. Prihadi et al. 1991. A comparative trial of the Tcu 380A, Lippes Loop D and Multiload Cu 375 IUDs in Indonesia. Contraception44: 141-154.
58.
Shelton, J.1991. What's wrong with CYP?Studies in Family Planning22: 332-335.
59.
Singh, K.
, O. Viegas, D. Liew, P. Singh, and S. Ratnam. 1988. Norplant-2 rods: One-year experience in Singapore. Contraception38 (4): 429-440.
60.
Sivin, I.1983. Findings in phase III studies of Norplant implants. In Long-acting steroid contraception, edited by D. R. Mishell, 89-116. New York: Raven Press.
61.
Sivin, I.1988. International experience with Norplant and Norplant-2 contraceptives. Studies in Family Planning19 (2): 81-94.
62.
Sivin, I.
, S. El Mahgoub, T. McCarthy, D. R. Mishell, D. Shoupe, F. Alvarez, V. Brache, E. Jimenez, J. Diaz, and A. Faundes. 1990. Long-term contraception with the Levonorgestrel 20mcg/day (1Ng20) and the Copper T 380Ag intrauterine devices: A five-year randomized study. Contraception42 (4): 361-378.
63.
Sivin, I.
, P. Holma, S. Diaz, F. Alvarez-Sanchez, D. Robertson, and J. Stern. 1984. Long-term experience with Norplant implants in international clinical trials. Contraceptive Delivery Systems5 (1): 53-62.
64.
Stover, J.
, J. T. Bertrand, S. Smith, N. Rutenberg, and K. Meyer-Ramirez. 1977. Empirically based conversion factors for calculating couple-years of protection. Chapel Hill, NC: Carolina Population Center.
65.
Stover, J.
, and L. Heaton. 1997. The costs of contraceptive social marketing programs implemented through the SOMARC project. Glastonbury, CT: The Futures Group International.
66.
Stover, J.
, J. C. Knowles, A. E. Wagman, and D. L. Nortman. 1991. Target-cost, a model for projecting the family planning service requirements and costs to achieve demographic goals. December. Glastonbury, CT: The Futures Group International.
67.
Sujuan, G.
, D. Mingun, Y. Dao Yuan, Z. Ling De, X. Fang, L. Ying-Lin, W. Hua, W. Ling, W. Fei-Zhu, G. Yun-Li, H. Xin, Q. Li-Fang, C. Chang-Rong, L. Fing, M. Fing, and I. Sivin. 1988. A two-year study of acceptability, side effects, and effectiveness of Norplant and Norplant-2 implants in the People's Republic of China. Contraception38 (6): 641-657.
68.
Tahir, Z.
, G. Cernada, G. Huschle-Delobel, U. Rob, L. Lush, and M. S. Ahmad. 1995. Family planning operations research and program evaluation literature review: A selected annotated bibliography: Pakistan 1968-1993. International Quarterly of Community Health Education15 (3): 291-324.
69.
Thapa, S.
, S. Kumar, J. Cushing, and K. Kennedy. 1992. Contraceptive use among postpartum women: Recent patterns and programmatic implications. International Family Planning Perspectives18: 83-91.
70.
Toppozada, H., S. Koetsawang, V. Aimakhu, T. Khan, A. Pretnar-Darovec, T. Chatterjee, M. Molitor-Peffer, R. Apelo, R. Lichtenberg, P. Crosignani, J. de Souza, C. Gomez-Rogers, and A. Haspels. 1983. Multinational comparative clinical trial of long-acting injectable contraceptives: Norethisterone Enanthate given in two dosage regimens and Depot-Medroxyprogesterone Acetate. Final report. Paper No. M83. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction.
71.
Trussell, J.
, and L. Grummer-Strawn. 1990. Contraceptive failure of the ovulation method of periodic abstinence. International Family Planning Perspectives16 (1): 5-15.
72.
Tsui, A. O.
, S. V. de Silva, and R. Marinshaw. 1991. Pregnancy avoidance and coital behavior. Demography28: 101-117.
73.
Udry, R.1980. Changes in the frequency of marital intercourse from panel data. Archives of Sexual Behavior9 (4): 319-324.
74.
United Nations
. 1977. World population prospects as assessed in 1973. Department of Economic and Social Affairs, Population Studies No. 60. New York: Author.
75.
United Nations
. 1991. Measuring the dynamics of contraceptive use. New York: Author.
76.
United Nations Development Programme/United National Population Fund/World Health Organization/World Bank, Special Programme of Research, Development and Research Training in Human Reproduction: IUD Research Group
. 1994. A randomized multicentre trial of the Multiload 375 and Tcu 380A IUDs in parous women: Three-year results. Contraception49: 543-549.
77.
Vernon, R.
, K. Rocuts, and J. E. Medina. 1987. The provision of natural family planning services at public health centers in Colombia. International Family Planning Perspectives13 (4): 121-127.
78.
Virutamasen, P.1987. Long-acting injectable contraceptives—current status. In Recent advances in contraceptive technology, 86-92. Proceedings held in Chaing Mai, Thailand, Kuala Lumpar, Malaysia, IPPF, ESEAOR.
79.
Wade, K. B.
, F. Sevilla, and M. H. Labbok. 1994. Integrating the lactational amenorrhea method into a family planning program in Ecuador. Studies in Family Planning25 (May/June): 162-175.
80.
Wilson, J. C.1992. A New Zealand randomized comparative study of three IUDs (Nova-T, MLCu375, MLAgCu250): 1-, 2-, and 3-year results. Advances in Contraception8 (2): 153-159.
81.
Wishik, S.
, and K. Chen. 1973. Couple-years of protection: A measure of family planning program output. New York: International Institute for the Study of Human Reproduction, Columbia University.
82.
Wolfers, D.1975. Births averted. In Measuring the effect of family planning programs on fertility, edited by C. Chandrasekaran and A. Hermalin, 163-208. Dolhain, Belgium: Ordina Editions.
